Company CVAbout Kimia Biosciences Ltd 
Kimia Biosciences Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal. The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana. The Company is engaged into the business of Pharamaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr.
Company Coordinates
Company Details
Bhondsi Village, Tehsil Sohna Gurgaon Haryana : 122102
Registrar Details
Beetal Financial & Computer Services (P) Ltd , Beetal House , 99 Mandangir, 3rd Floor, Behind Local Shopping Centre, Near Dada Harsukhdas Mandir, New Delhi
Capital StructureCapital Structure
Present Equity Capital
INR 4.73 Cr
Number of Shares
4.73 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
26-Jun-2020
4.73
4.73
958790
1
Preference Share Conversion
28-Jan-2020
4.64
4.64
5559530
1
Preference Share Conversion
28-Jan-2020
4.64
4.64
5559530
1
Preference Share Conversion
01-Jul-2019
4.08
4.08
17468000
1
Conversion of Warrants
01-Jul-2019
4.08
4.08
17468000
1
Conversion of Warrants
19-Jun-2019
2.33
2.33
8732000
1
Conversion of Warrants
19-Jun-2019
2.33
2.33
8732000
1
Conversion of Warrants
15-Nov-2018
73.85
0.74
0
1
Capital Reduction
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 3 Schemes (0.38%)
FIIs
Held by 0 FIIs
Promoter with highest holding
Sameer Goel (74.94%)
Highest Public shareholder
Anish Kumar Agarwal (4.33%)
Individual Investors Holdings
22.93%
Board of Directors
Management
Designation
Remuneration
Sameer Goel
Chairman & Managing Director
60.0 lacs
Jagdeep Dhavvan
Independent Director
0
Richa Gupta
Independent Director
0
Vipul Goel
Director
0
Lakshay Prakash
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Chemical
74.5502
0%
Chemical
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Processing Charges
0.00
0.00%
Processing Charges
Stock DNARevenue and Profits:
Net Sales:
34 Cr
(Quarterly Results - Sep 2025)
Net Profit:
1 Cr
Pharmaceuticals & Biotechnology
INR 142 Cr (Micro Cap)
17.00
27
0.00%
3.05
70.64%
12.07
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
